FDA Approved: COMBIGAN — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for COMBIGAN (brimonidine tartrate and timolol maleate) submitted by Allergan, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Combigan (brimonidine tartrate and timolol maleate)

Snippet

SUPPL AP for COMBIGAN (BRIMONIDINE TARTRATE, TIMOLOL MALEATE)